ImageneBio Inc. (IMA)

NasdaqCM: IMA · 실시간 가격 · USD

5.61

+0.10 (1.81%)

종가 기준: Aug 20, 2026, 8:00 PM

5.69

+1.43%

애프터마켓: 4:10 PM

1.81% (1D)

데이터 없음

매수호가	4.07
시가총액	63.68M
매출 (ttm)	n/a
순이익 (ttm)	-53.33M
베타	n/a
EPS (ttm)	-4.81
P/E (ttm)	n/a
선행 P/E	-1.51
P/B (ttm)	0.45
P/S (ttm)	n/a
Earnings Date	n/a

매도호가	7.23
거래량	3,217
평균 거래량 (20일)	12,304
시가	5.75
전일 종가	5.51
일중 범위	5.61 - 5.75
52주 범위	3.94 - 14.34
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

IMA 소개

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its nam...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Mar 26, 2021

직원 수 18

상장 거래소 NasdaqCM

티커 IMA

웹사이트 https://www.inmagenebio.com

전체 기업 정보

재무 실적

2025년 ImageneBio의 매출은 800K로, 전년 3.5M 대비 -77.14% 감소했습니다. 순이익은 -45.35M로, 24.01% 증가했습니다.

재무제표

어닝 서프라이즈

ImageneBio가 Aug 5, 2026에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.

EPS -0.63 예상치 상회 0.35, 및 -Infinity% 전년 대비 감소.

뉴스

4개월 전 · Simply Wall St.

Image Resources NL (ASX:IMA) Is About To Turn The Corner

With the business potentially at an important milestone, we thought we'd take a closer look at Image Resources NL's...

4개월 전 · TipRanks

Imax announces $28M opening weekend for Amazon/MGM/s ‘Project Hail Mary’

IMAX (IMAX) Corporation announces the opening weekend for Amazon (AMZN) / MGM Studies’ “Project Hail Mary,” with IMAX delivering $28M at the global box office. The latest Filmed For IMAX release from ...

7개월 전 · Simply Wall St.

ImageneBio Insider Confidence Rewarded, Stock Hits US$76m Market Cap

ImageneBio, Inc. ( NASDAQ:IMA ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

9개월 전 · Simply Wall St.

Here's Why We're Watching ImageneBio's (NASDAQ:IMA) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

ImageneBio Inc. (IMA)